breseq  version 0.33.1  revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence
  seq id position ref new freq score (cons/poly) reads annotation genes product
*USA300TCH1516_ALE512,6430AG49.5% ‑4.0 / 129.2 99intergenic (+711/‑6052)recR/speA_2Recombination protein RecR/Arginine decarboxylase
*USA300TCH1516_ALE111,5120AG26.4% 120.9 / 37.0 73S194S (TCA→TCGUSA300HOU_RS00520putative lipoprotein
*USA300TCH1516_ALE111,5160CA25.0% 119.4 / 34.3 69Q196K (CAA→AAA) USA300HOU_RS00520putative lipoprotein

Marginal new junction evidence (lowest skew 10 of 19 shown)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? USA300TCH1516_ALE 52495 =72 (1.260)161 (2.840)
+T
9/266 3.6 67.8% intergenic (+105/‑568) USA300HOU_RS00215/USA300HOU_RS00220 hypothetical protein/hypothetical protein
?USA300TCH1516_ALE = 52988 82 (1.430)intergenic (+598/‑75) USA300HOU_RS00215/USA300HOU_RS00220 hypothetical protein/hypothetical protein
* ? USA300TCH1516_ALE 52489 =74 (1.290)33 (0.650) 5/238 4.6 31.5% intergenic (+99/‑574) USA300HOU_RS00215/USA300HOU_RS00220 hypothetical protein/hypothetical protein
?USA300TCH1516_ALE = 52983 78 (1.540)intergenic (+593/‑80) USA300HOU_RS00215/USA300HOU_RS00220 hypothetical protein/hypothetical protein
* ? USA300TCH1516_ALE 37094 =77 (1.350)4 (0.080) 4/248 5.2 5.3% intergenic (+118/‑719) USA300HOU_RS14915/ugpQ_1 hypothetical protein/Glycerophosphodiester phosphodiesterase, cytoplasmic
?USA300TCH1516_ALE 37188 = 72 (1.360)intergenic (+212/‑625) USA300HOU_RS14915/ugpQ_1 hypothetical protein/Glycerophosphodiester phosphodiesterase, cytoplasmic
* ? USA300TCH1516_ALE = 614093124 (2.170)6 (0.110) 3/264 6.0 4.8% coding (2405/2844 nt) sdrC Serine‑aspartate repeat‑containing protein C
?USA300TCH1516_ALE 614118 = 114 (2.020)coding (2430/2844 nt) sdrC Serine‑aspartate repeat‑containing protein C
* ? USA300TCH1516_ALE = 45629444 (0.770)3 (0.050) 3/262 6.0 7.1% intergenic (+216/‑150) speC_5/tst_4 Exotoxin type C/Toxic shock syndrome toxin‑1
?USA300TCH1516_ALE = 456337 35 (0.630)intergenic (+259/‑107) speC_5/tst_4 Exotoxin type C/Toxic shock syndrome toxin‑1
* ? CP000731 = 4381230 (0.960)4 (0.010) 4/254 18.5 0.58% intergenic (+346/‑119) USA300HOU_pUSA300HOUMR0006/cadR hypothetical protein/cadmium binding protein
?NC_012417 = 1975 1153 (1.160)intergenic (+208/+118) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 2365 =282 (1.180)4 (0.010) 4/252 18.5 0.56% intergenic (+145/+23) USA300HOU_pUSA300HOUMR0003/USA300HOU_pUSA300HOUMR0004 hypothetical protein/hypothetical protein
?NC_012417 1955 = 1167 (1.180)intergenic (+188/+138) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 2365 =282 (1.180)4 (0.020) 4/252 18.5 1.4% intergenic (+145/+23) USA300HOU_pUSA300HOUMR0003/USA300HOU_pUSA300HOUMR0004 hypothetical protein/hypothetical protein
?CP000731 4302 = 282 (1.260)intergenic (+267/‑198) USA300HOU_pUSA300HOUMR0006/cadR hypothetical protein/cadmium binding protein
* ? CP000731 = 2334292 (1.220)4 (0.010) 4/254 18.5 0.56% intergenic (+114/+54) USA300HOU_pUSA300HOUMR0003/USA300HOU_pUSA300HOUMR0004 hypothetical protein/hypothetical protein
?NC_012417 = 1975 1153 (1.160)intergenic (+208/+118) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 4311 =284 (1.190)6 (0.010) 3/246 19.1 0.92% intergenic (+276/‑189) USA300HOU_pUSA300HOUMR0006/cadR hypothetical protein/cadmium binding protein
?NC_012417 2053 = 1037 (1.080)intergenic (+286/+40) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein